Glucagon-like peptide-1 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Glucagon-like peptide-1" in English language version.

refsWebsite

Global rank English rank

39nih.gov

4^th place

32doi.org

2^nd place

12semanticscholar.org

11^th place

8^th place

5worldcat.org

5^th place

2harvard.edu

18^th place

17^th place

2science.org

1,160^th place

737^th place

1medscape.com

719^th place

636^th place

1jci.org

low place

doi.org

Marathe CS, Rayner CK, Jones KL, Horowitz M (June 2013). "Glucagon-like peptides 1 and 2 in health and disease: a review". Peptides. 44: 75–86. doi:10.1016/j.peptides.2013.01.014. PMID 23523778. S2CID 22641629.
Baggio LL, Drucker DJ (May 2007). "Biology of incretins: GLP-1 and GIP". Gastroenterology. 132 (6): 2131–57. doi:10.1053/j.gastro.2007.03.054. PMID 17498508.
Holst JJ (October 2007). "The physiology of glucagon-like peptide 1". Physiological Reviews. 87 (4): 1409–39. doi:10.1152/physrev.00034.2006. PMID 17928588.
Deacon CF, Holst JJ (August 2009). "Immunoassays for the incretin hormones GIP and GLP-1". Best Practice & Research. Clinical Endocrinology & Metabolism. 23 (4): 425–32. doi:10.1016/j.beem.2009.03.006. PMID 19748060.
Ma X, Guan Y, Hua X (September 2014). "Glucagon-like peptide 1-potentiated insulin secretion and proliferation of pancreatic β-cells". Journal of Diabetes. 6 (5): 394–402. doi:10.1111/1753-0407.12161. PMID 24725840. S2CID 13300428.
Deacon CF (2004). "Circulation and degradation of GIP and GLP-1". Hormone and Metabolic Research. 36 (11–12): 761–5. doi:10.1055/s-2004-826160. PMID 15655705. S2CID 24730915.
Toft-Nielsen MB, Madsbad S, Holst JJ (August 2001). "Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes". The Journal of Clinical Endocrinology and Metabolism. 86 (8): 3853–60. doi:10.1210/jcem.86.8.7743. PMID 11502823.
Meier JJ, Weyhe D, Michaely M, Senkal M, Zumtobel V, Nauck MA, Holst JJ, Schmidt WE, Gallwitz B (March 2004). "Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes". Critical Care Medicine. 32 (3): 848–51. doi:10.1097/01.CCM.0000114811.60629.B5. PMID 15090972. S2CID 2382791.
Graaf C, Donnelly D, Wootten D, Lau J, Sexton PM, Miller LJ, Ahn JM, Liao J, Fletcher MM, Yang D, Brown AJ, Zhou C, Deng J, Wang MW (October 2016). "Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes". Pharmacological Reviews. 68 (4): 954–1013. doi:10.1124/pr.115.011395. PMC 5050443. PMID 27630114.
Calanna S, Christensen M, Holst JJ, Laferrère B, Gluud LL, Vilsbøll T, Knop FK (May 2013). "Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies". Diabetologia. 56 (5): 965–72. doi:10.1007/s00125-013-2841-0. PMC 3687347. PMID 23377698.
Rondas D, D'Hertog W, Overbergh L, Mathieu C (September 2013). "Glucagon-like peptide-1: modulator of β-cell dysfunction and death". Diabetes, Obesity & Metabolism. 15 Suppl 3 (3): 185–92. doi:10.1111/dom.12165. PMID 24003936.
Rachmany L, Tweedie D, Li Y, Rubovitch V, Holloway HW, Miller J, Hoffer BJ, Greig NH, Pick CG (October 2013). "Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in mice". Age. 35 (5): 1621–36. doi:10.1007/s11357-012-9464-0. PMC 3776106. PMID 22892942.
Gautier JF, Choukem SP, Girard J (2008). "Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes". Diabetes & Metabolism. 34: S65–S72. doi:10.1016/S1262-3636(08)73397-4. PMID 18640588.
Seino Y, Fukushima M, Yabe D (April 2010). "GIP and GLP-1, the two incretin hormones: Similarities and differences". Journal of Diabetes Investigation. 1 (1–2): 8–23. doi:10.1111/j.2040-1124.2010.00022.x. PMC 4020673. PMID 24843404.
Li H, Lee CH, Yoo KY, Choi JH, Park OK, Yan BC, Byun K, Lee B, Hwang IK, Won MH (December 2010). "Chronic treatment of exendin-4 affects cell proliferation and neuroblast differentiation in the adult mouse hippocampal dentate gyrus". Neuroscience Letters. 486 (1): 38–42. doi:10.1016/j.neulet.2010.09.040. PMID 20854877. S2CID 33327108.
Bertilsson G, Patrone C, Zachrisson O, Andersson A, Dannaeus K, Heidrich J, Kortesmaa J, Mercer A, Nielsen E, Rönnholm H, Wikström L (February 2008). "Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease". Journal of Neuroscience Research. 86 (2): 326–38. doi:10.1002/jnr.21483. PMID 17803225. S2CID 40330443.
DellaValle B, Hempel C, Johansen FF, Kurtzhals JA (September 2014). "GLP-1 improves neuropathology after murine cold lesion brain trauma". Annals of Clinical and Translational Neurology. 1 (9): 721–32. doi:10.1002/acn3.99. PMC 4241798. PMID 25493285.
Wang MD, Huang Y, Zhang GP, Mao L, Xia YP, Mei YW, Hu B (December 2012). "Exendin-4 improved rat cortical neuron survival under oxygen/glucose deprivation through PKA pathway". Neuroscience. 226: 388–96. doi:10.1016/j.neuroscience.2012.09.025. PMID 23000625. S2CID 36908739.
Sharma MK, Jalewa J, Hölscher C (February 2014). "Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress". Journal of Neurochemistry. 128 (3): 459–71. doi:10.1111/jnc.12469. PMID 24112036.
Perry T, Haughey NJ, Mattson MP, Egan JM, Greig NH (September 2002). "Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4". The Journal of Pharmacology and Experimental Therapeutics. 302 (3): 881–8. doi:10.1124/jpet.102.037481. PMID 12183643. S2CID 43716740.
Iwai T, Sawabe T, Tanimitsu K, Suzuki M, Sasaki-Hamada S, Oka J (April 2014). "Glucagon-like peptide-1 protects synaptic and learning functions from neuroinflammation in rodents". Journal of Neuroscience Research. 92 (4): 446–54. doi:10.1002/jnr.23335. PMID 24464856. S2CID 206129862.
Li Y, Perry T, Kindy MS, Harvey BK, Tweedie D, Holloway HW, Powers K, Shen H, Egan JM, Sambamurti K, Brossi A, Lahiri DK, Mattson MP, Hoffer BJ, Wang Y, Greig NH (January 2009). "GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism". Proceedings of the National Academy of Sciences of the United States of America. 106 (4): 1285–90. Bibcode:2009PNAS..106.1285L. doi:10.1073/pnas.0806720106. PMC 2633544. PMID 19164583.
Wang XH, Li L, Hölscher C, Pan YF, Chen XR, Qi JS (November 2010). "Val8-glucagon-like peptide-1 protects against Aβ1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats". Neuroscience. 170 (4): 1239–48. doi:10.1016/j.neuroscience.2010.08.028. PMID 20727946. S2CID 44318394.
Perry T, Lahiri DK, Sambamurti K, Chen D, Mattson MP, Egan JM, Greig NH (June 2003). "Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron". Journal of Neuroscience Research. 72 (5): 603–12. doi:10.1002/jnr.10611. PMID 12749025. S2CID 83852654.
DellaValle B, Brix GS, Brock B, Gejl M, Landau AM, Møller A, Rungby J, Larsen A (2016). "Glucagon-Like Peptide-1 Analog, Liraglutide, Delays Onset of Experimental Autoimmune Encephalitis in Lewis Rats". Frontiers in Pharmacology. 7: 433. doi:10.3389/fphar.2016.00433. PMC 5114298. PMID 27917122.
Her work paved the way for blockbuster obesity drugs. Now, she's fighting for recognition (Report). 2023-09-08. doi:10.1126/science.adk7627.
Mojsov S (1992). "Structural requirements for biological activity of glucagon-like peptide-I". International Journal of Peptide and Protein Research. 40 (3–4): 333–343. doi:10.1111/j.1399-3011.1992.tb00309.x. ISSN 0367-8377. PMID 1478791.
Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF (September 1986). "Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing". Journal of Biological Chemistry. 261 (25): 11880–11889. doi:10.1016/s0021-9258(18)67324-7. ISSN 0021-9258. PMID 3528148.
Mojsov S, Weir GC, Habener JF (1987-02-01). "Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas". Journal of Clinical Investigation. 79 (2): 616–619. doi:10.1172/JCI112855. ISSN 0021-9738. PMC 424143. PMID 3543057.
Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF (May 1987). "Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line". Proceedings of the National Academy of Sciences of the United States of America. 84 (10): 3434–3438. Bibcode:1987PNAS...84.3434D. doi:10.1073/pnas.84.10.3434. ISSN 0027-8424. PMC 304885. PMID 3033647.
O'Rahilly S (2021-04-15). "The islet's bridesmaid becomes the bride: Proglucagon-derived peptides deliver transformative therapies". Cell. 184 (8): 1945–1948. doi:10.1016/j.cell.2021.03.019. ISSN 0092-8674. PMID 33831374. S2CID 233131461.
Her work paved the way for blockbuster obesity drugs. Now, she's fighting for recognition (Report). 2023-09-08. doi:10.1126/science.adk7627.

harvard.edu

ui.adsabs.harvard.edu

Li Y, Perry T, Kindy MS, Harvey BK, Tweedie D, Holloway HW, Powers K, Shen H, Egan JM, Sambamurti K, Brossi A, Lahiri DK, Mattson MP, Hoffer BJ, Wang Y, Greig NH (January 2009). "GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism". Proceedings of the National Academy of Sciences of the United States of America. 106 (4): 1285–90. Bibcode:2009PNAS..106.1285L. doi:10.1073/pnas.0806720106. PMC 2633544. PMID 19164583.
Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF (May 1987). "Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line". Proceedings of the National Academy of Sciences of the United States of America. 84 (10): 3434–3438. Bibcode:1987PNAS...84.3434D. doi:10.1073/pnas.84.10.3434. ISSN 0027-8424. PMC 304885. PMID 3033647.

jci.org

Mojsov S, Weir GC, Habener JF (1987-02-01). "Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas". Journal of Clinical Investigation. 79 (2): 616–619. doi:10.1172/JCI112855. ISSN 0021-9738. PMC 424143. PMID 3543057.

medscape.com

"Diabetes and Intestinal Incretin Hormones: A New Therapeutic Paradigm" at medscape.com (slide 36)

nih.gov

pubmed.ncbi.nlm.nih.gov

Marathe CS, Rayner CK, Jones KL, Horowitz M (June 2013). "Glucagon-like peptides 1 and 2 in health and disease: a review". Peptides. 44: 75–86. doi:10.1016/j.peptides.2013.01.014. PMID 23523778. S2CID 22641629.
Baggio LL, Drucker DJ (May 2007). "Biology of incretins: GLP-1 and GIP". Gastroenterology. 132 (6): 2131–57. doi:10.1053/j.gastro.2007.03.054. PMID 17498508.
Holst JJ (October 2007). "The physiology of glucagon-like peptide 1". Physiological Reviews. 87 (4): 1409–39. doi:10.1152/physrev.00034.2006. PMID 17928588.
Deacon CF, Holst JJ (August 2009). "Immunoassays for the incretin hormones GIP and GLP-1". Best Practice & Research. Clinical Endocrinology & Metabolism. 23 (4): 425–32. doi:10.1016/j.beem.2009.03.006. PMID 19748060.
Ma X, Guan Y, Hua X (September 2014). "Glucagon-like peptide 1-potentiated insulin secretion and proliferation of pancreatic β-cells". Journal of Diabetes. 6 (5): 394–402. doi:10.1111/1753-0407.12161. PMID 24725840. S2CID 13300428.
Deacon CF (2004). "Circulation and degradation of GIP and GLP-1". Hormone and Metabolic Research. 36 (11–12): 761–5. doi:10.1055/s-2004-826160. PMID 15655705. S2CID 24730915.
Toft-Nielsen MB, Madsbad S, Holst JJ (August 2001). "Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes". The Journal of Clinical Endocrinology and Metabolism. 86 (8): 3853–60. doi:10.1210/jcem.86.8.7743. PMID 11502823.
Meier JJ, Weyhe D, Michaely M, Senkal M, Zumtobel V, Nauck MA, Holst JJ, Schmidt WE, Gallwitz B (March 2004). "Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes". Critical Care Medicine. 32 (3): 848–51. doi:10.1097/01.CCM.0000114811.60629.B5. PMID 15090972. S2CID 2382791.
Graaf C, Donnelly D, Wootten D, Lau J, Sexton PM, Miller LJ, Ahn JM, Liao J, Fletcher MM, Yang D, Brown AJ, Zhou C, Deng J, Wang MW (October 2016). "Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes". Pharmacological Reviews. 68 (4): 954–1013. doi:10.1124/pr.115.011395. PMC 5050443. PMID 27630114.
Calanna S, Christensen M, Holst JJ, Laferrère B, Gluud LL, Vilsbøll T, Knop FK (May 2013). "Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies". Diabetologia. 56 (5): 965–72. doi:10.1007/s00125-013-2841-0. PMC 3687347. PMID 23377698.
Rondas D, D'Hertog W, Overbergh L, Mathieu C (September 2013). "Glucagon-like peptide-1: modulator of β-cell dysfunction and death". Diabetes, Obesity & Metabolism. 15 Suppl 3 (3): 185–92. doi:10.1111/dom.12165. PMID 24003936.
Rachmany L, Tweedie D, Li Y, Rubovitch V, Holloway HW, Miller J, Hoffer BJ, Greig NH, Pick CG (October 2013). "Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in mice". Age. 35 (5): 1621–36. doi:10.1007/s11357-012-9464-0. PMC 3776106. PMID 22892942.
Gautier JF, Choukem SP, Girard J (2008). "Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes". Diabetes & Metabolism. 34: S65–S72. doi:10.1016/S1262-3636(08)73397-4. PMID 18640588.
Seino Y, Fukushima M, Yabe D (April 2010). "GIP and GLP-1, the two incretin hormones: Similarities and differences". Journal of Diabetes Investigation. 1 (1–2): 8–23. doi:10.1111/j.2040-1124.2010.00022.x. PMC 4020673. PMID 24843404.
Li H, Lee CH, Yoo KY, Choi JH, Park OK, Yan BC, Byun K, Lee B, Hwang IK, Won MH (December 2010). "Chronic treatment of exendin-4 affects cell proliferation and neuroblast differentiation in the adult mouse hippocampal dentate gyrus". Neuroscience Letters. 486 (1): 38–42. doi:10.1016/j.neulet.2010.09.040. PMID 20854877. S2CID 33327108.
Bertilsson G, Patrone C, Zachrisson O, Andersson A, Dannaeus K, Heidrich J, Kortesmaa J, Mercer A, Nielsen E, Rönnholm H, Wikström L (February 2008). "Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease". Journal of Neuroscience Research. 86 (2): 326–38. doi:10.1002/jnr.21483. PMID 17803225. S2CID 40330443.
DellaValle B, Hempel C, Johansen FF, Kurtzhals JA (September 2014). "GLP-1 improves neuropathology after murine cold lesion brain trauma". Annals of Clinical and Translational Neurology. 1 (9): 721–32. doi:10.1002/acn3.99. PMC 4241798. PMID 25493285.
Wang MD, Huang Y, Zhang GP, Mao L, Xia YP, Mei YW, Hu B (December 2012). "Exendin-4 improved rat cortical neuron survival under oxygen/glucose deprivation through PKA pathway". Neuroscience. 226: 388–96. doi:10.1016/j.neuroscience.2012.09.025. PMID 23000625. S2CID 36908739.
Sharma MK, Jalewa J, Hölscher C (February 2014). "Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress". Journal of Neurochemistry. 128 (3): 459–71. doi:10.1111/jnc.12469. PMID 24112036.
Perry T, Haughey NJ, Mattson MP, Egan JM, Greig NH (September 2002). "Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4". The Journal of Pharmacology and Experimental Therapeutics. 302 (3): 881–8. doi:10.1124/jpet.102.037481. PMID 12183643. S2CID 43716740.
Iwai T, Sawabe T, Tanimitsu K, Suzuki M, Sasaki-Hamada S, Oka J (April 2014). "Glucagon-like peptide-1 protects synaptic and learning functions from neuroinflammation in rodents". Journal of Neuroscience Research. 92 (4): 446–54. doi:10.1002/jnr.23335. PMID 24464856. S2CID 206129862.
Li Y, Perry T, Kindy MS, Harvey BK, Tweedie D, Holloway HW, Powers K, Shen H, Egan JM, Sambamurti K, Brossi A, Lahiri DK, Mattson MP, Hoffer BJ, Wang Y, Greig NH (January 2009). "GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism". Proceedings of the National Academy of Sciences of the United States of America. 106 (4): 1285–90. Bibcode:2009PNAS..106.1285L. doi:10.1073/pnas.0806720106. PMC 2633544. PMID 19164583.
Wang XH, Li L, Hölscher C, Pan YF, Chen XR, Qi JS (November 2010). "Val8-glucagon-like peptide-1 protects against Aβ1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats". Neuroscience. 170 (4): 1239–48. doi:10.1016/j.neuroscience.2010.08.028. PMID 20727946. S2CID 44318394.
Perry T, Lahiri DK, Sambamurti K, Chen D, Mattson MP, Egan JM, Greig NH (June 2003). "Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron". Journal of Neuroscience Research. 72 (5): 603–12. doi:10.1002/jnr.10611. PMID 12749025. S2CID 83852654.
DellaValle B, Brix GS, Brock B, Gejl M, Landau AM, Møller A, Rungby J, Larsen A (2016). "Glucagon-Like Peptide-1 Analog, Liraglutide, Delays Onset of Experimental Autoimmune Encephalitis in Lewis Rats". Frontiers in Pharmacology. 7: 433. doi:10.3389/fphar.2016.00433. PMC 5114298. PMID 27917122.
Mojsov S (1992). "Structural requirements for biological activity of glucagon-like peptide-I". International Journal of Peptide and Protein Research. 40 (3–4): 333–343. doi:10.1111/j.1399-3011.1992.tb00309.x. ISSN 0367-8377. PMID 1478791.
Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF (September 1986). "Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing". Journal of Biological Chemistry. 261 (25): 11880–11889. doi:10.1016/s0021-9258(18)67324-7. ISSN 0021-9258. PMID 3528148.
Mojsov S, Weir GC, Habener JF (1987-02-01). "Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas". Journal of Clinical Investigation. 79 (2): 616–619. doi:10.1172/JCI112855. ISSN 0021-9738. PMC 424143. PMID 3543057.
Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF (May 1987). "Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line". Proceedings of the National Academy of Sciences of the United States of America. 84 (10): 3434–3438. Bibcode:1987PNAS...84.3434D. doi:10.1073/pnas.84.10.3434. ISSN 0027-8424. PMC 304885. PMID 3033647.
O'Rahilly S (2021-04-15). "The islet's bridesmaid becomes the bride: Proglucagon-derived peptides deliver transformative therapies". Cell. 184 (8): 1945–1948. doi:10.1016/j.cell.2021.03.019. ISSN 0092-8674. PMID 33831374. S2CID 233131461.

ncbi.nlm.nih.gov

Graaf C, Donnelly D, Wootten D, Lau J, Sexton PM, Miller LJ, Ahn JM, Liao J, Fletcher MM, Yang D, Brown AJ, Zhou C, Deng J, Wang MW (October 2016). "Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes". Pharmacological Reviews. 68 (4): 954–1013. doi:10.1124/pr.115.011395. PMC 5050443. PMID 27630114.
Calanna S, Christensen M, Holst JJ, Laferrère B, Gluud LL, Vilsbøll T, Knop FK (May 2013). "Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies". Diabetologia. 56 (5): 965–72. doi:10.1007/s00125-013-2841-0. PMC 3687347. PMID 23377698.
Rachmany L, Tweedie D, Li Y, Rubovitch V, Holloway HW, Miller J, Hoffer BJ, Greig NH, Pick CG (October 2013). "Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in mice". Age. 35 (5): 1621–36. doi:10.1007/s11357-012-9464-0. PMC 3776106. PMID 22892942.
Seino Y, Fukushima M, Yabe D (April 2010). "GIP and GLP-1, the two incretin hormones: Similarities and differences". Journal of Diabetes Investigation. 1 (1–2): 8–23. doi:10.1111/j.2040-1124.2010.00022.x. PMC 4020673. PMID 24843404.
DellaValle B, Hempel C, Johansen FF, Kurtzhals JA (September 2014). "GLP-1 improves neuropathology after murine cold lesion brain trauma". Annals of Clinical and Translational Neurology. 1 (9): 721–32. doi:10.1002/acn3.99. PMC 4241798. PMID 25493285.
Li Y, Perry T, Kindy MS, Harvey BK, Tweedie D, Holloway HW, Powers K, Shen H, Egan JM, Sambamurti K, Brossi A, Lahiri DK, Mattson MP, Hoffer BJ, Wang Y, Greig NH (January 2009). "GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism". Proceedings of the National Academy of Sciences of the United States of America. 106 (4): 1285–90. Bibcode:2009PNAS..106.1285L. doi:10.1073/pnas.0806720106. PMC 2633544. PMID 19164583.
DellaValle B, Brix GS, Brock B, Gejl M, Landau AM, Møller A, Rungby J, Larsen A (2016). "Glucagon-Like Peptide-1 Analog, Liraglutide, Delays Onset of Experimental Autoimmune Encephalitis in Lewis Rats". Frontiers in Pharmacology. 7: 433. doi:10.3389/fphar.2016.00433. PMC 5114298. PMID 27917122.
Mojsov S, Weir GC, Habener JF (1987-02-01). "Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas". Journal of Clinical Investigation. 79 (2): 616–619. doi:10.1172/JCI112855. ISSN 0021-9738. PMC 424143. PMID 3543057.
Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF (May 1987). "Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line". Proceedings of the National Academy of Sciences of the United States of America. 84 (10): 3434–3438. Bibcode:1987PNAS...84.3434D. doi:10.1073/pnas.84.10.3434. ISSN 0027-8424. PMC 304885. PMID 3033647.

science.org

Her work paved the way for blockbuster obesity drugs. Now, she's fighting for recognition (Report). 2023-09-08. doi:10.1126/science.adk7627.
Her work paved the way for blockbuster obesity drugs. Now, she's fighting for recognition (Report). 2023-09-08. doi:10.1126/science.adk7627.

semanticscholar.org

api.semanticscholar.org

Marathe CS, Rayner CK, Jones KL, Horowitz M (June 2013). "Glucagon-like peptides 1 and 2 in health and disease: a review". Peptides. 44: 75–86. doi:10.1016/j.peptides.2013.01.014. PMID 23523778. S2CID 22641629.
Ma X, Guan Y, Hua X (September 2014). "Glucagon-like peptide 1-potentiated insulin secretion and proliferation of pancreatic β-cells". Journal of Diabetes. 6 (5): 394–402. doi:10.1111/1753-0407.12161. PMID 24725840. S2CID 13300428.
Deacon CF (2004). "Circulation and degradation of GIP and GLP-1". Hormone and Metabolic Research. 36 (11–12): 761–5. doi:10.1055/s-2004-826160. PMID 15655705. S2CID 24730915.
Meier JJ, Weyhe D, Michaely M, Senkal M, Zumtobel V, Nauck MA, Holst JJ, Schmidt WE, Gallwitz B (March 2004). "Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes". Critical Care Medicine. 32 (3): 848–51. doi:10.1097/01.CCM.0000114811.60629.B5. PMID 15090972. S2CID 2382791.
Li H, Lee CH, Yoo KY, Choi JH, Park OK, Yan BC, Byun K, Lee B, Hwang IK, Won MH (December 2010). "Chronic treatment of exendin-4 affects cell proliferation and neuroblast differentiation in the adult mouse hippocampal dentate gyrus". Neuroscience Letters. 486 (1): 38–42. doi:10.1016/j.neulet.2010.09.040. PMID 20854877. S2CID 33327108.
Bertilsson G, Patrone C, Zachrisson O, Andersson A, Dannaeus K, Heidrich J, Kortesmaa J, Mercer A, Nielsen E, Rönnholm H, Wikström L (February 2008). "Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease". Journal of Neuroscience Research. 86 (2): 326–38. doi:10.1002/jnr.21483. PMID 17803225. S2CID 40330443.
Wang MD, Huang Y, Zhang GP, Mao L, Xia YP, Mei YW, Hu B (December 2012). "Exendin-4 improved rat cortical neuron survival under oxygen/glucose deprivation through PKA pathway". Neuroscience. 226: 388–96. doi:10.1016/j.neuroscience.2012.09.025. PMID 23000625. S2CID 36908739.
Perry T, Haughey NJ, Mattson MP, Egan JM, Greig NH (September 2002). "Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4". The Journal of Pharmacology and Experimental Therapeutics. 302 (3): 881–8. doi:10.1124/jpet.102.037481. PMID 12183643. S2CID 43716740.
Iwai T, Sawabe T, Tanimitsu K, Suzuki M, Sasaki-Hamada S, Oka J (April 2014). "Glucagon-like peptide-1 protects synaptic and learning functions from neuroinflammation in rodents". Journal of Neuroscience Research. 92 (4): 446–54. doi:10.1002/jnr.23335. PMID 24464856. S2CID 206129862.
Wang XH, Li L, Hölscher C, Pan YF, Chen XR, Qi JS (November 2010). "Val8-glucagon-like peptide-1 protects against Aβ1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats". Neuroscience. 170 (4): 1239–48. doi:10.1016/j.neuroscience.2010.08.028. PMID 20727946. S2CID 44318394.
Perry T, Lahiri DK, Sambamurti K, Chen D, Mattson MP, Egan JM, Greig NH (June 2003). "Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron". Journal of Neuroscience Research. 72 (5): 603–12. doi:10.1002/jnr.10611. PMID 12749025. S2CID 83852654.
O'Rahilly S (2021-04-15). "The islet's bridesmaid becomes the bride: Proglucagon-derived peptides deliver transformative therapies". Cell. 184 (8): 1945–1948. doi:10.1016/j.cell.2021.03.019. ISSN 0092-8674. PMID 33831374. S2CID 233131461.

worldcat.org

Mojsov S (1992). "Structural requirements for biological activity of glucagon-like peptide-I". International Journal of Peptide and Protein Research. 40 (3–4): 333–343. doi:10.1111/j.1399-3011.1992.tb00309.x. ISSN 0367-8377. PMID 1478791.
Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF (September 1986). "Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing". Journal of Biological Chemistry. 261 (25): 11880–11889. doi:10.1016/s0021-9258(18)67324-7. ISSN 0021-9258. PMID 3528148.
Mojsov S, Weir GC, Habener JF (1987-02-01). "Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas". Journal of Clinical Investigation. 79 (2): 616–619. doi:10.1172/JCI112855. ISSN 0021-9738. PMC 424143. PMID 3543057.
Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF (May 1987). "Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line". Proceedings of the National Academy of Sciences of the United States of America. 84 (10): 3434–3438. Bibcode:1987PNAS...84.3434D. doi:10.1073/pnas.84.10.3434. ISSN 0027-8424. PMC 304885. PMID 3033647.
O'Rahilly S (2021-04-15). "The islet's bridesmaid becomes the bride: Proglucagon-derived peptides deliver transformative therapies". Cell. 184 (8): 1945–1948. doi:10.1016/j.cell.2021.03.019. ISSN 0092-8674. PMID 33831374. S2CID 233131461.